These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
733 related items for PubMed ID: 24752710
1. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Int J Cancer; 2014 Dec 01; 135(11):2507-15. PubMed ID: 24752710 [Abstract] [Full Text] [Related]
2. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA. Am J Surg Pathol; 2006 Dec 01; 30(12):1491-501. PubMed ID: 17122504 [Abstract] [Full Text] [Related]
3. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH, Bae JM, Cho NY, Kang GH. Oncotarget; 2016 Mar 22; 7(12):14095-111. PubMed ID: 26883113 [Abstract] [Full Text] [Related]
4. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Ito M, Kanno S, Nosho K, Sukawa Y, Mitsuhashi K, Kurihara H, Igarashi H, Takahashi T, Tachibana M, Takahashi H, Yoshii S, Takenouchi T, Hasegawa T, Okita K, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Int J Cancer; 2015 Sep 15; 137(6):1258-68. PubMed ID: 25703934 [Abstract] [Full Text] [Related]
5. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA. Gut; 2004 Aug 15; 53(8):1137-44. PubMed ID: 15247181 [Abstract] [Full Text] [Related]
6. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential. Renaud F, Mariette C, Vincent A, Wacrenier A, Maunoury V, Leclerc J, Coppin L, Crépin M, Van Seuningen I, Leteurtre E, Buisine MP. Int J Cancer; 2016 Mar 15; 138(6):1472-81. PubMed ID: 26476272 [Abstract] [Full Text] [Related]
7. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway. Rhee YY, Kim KJ, Kang GH. Gut Liver; 2017 Jan 15; 11(1):38-46. PubMed ID: 27885175 [Abstract] [Full Text] [Related]
8. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD. Am J Surg Pathol; 2011 Sep 15; 35(9):1274-86. PubMed ID: 21836485 [Abstract] [Full Text] [Related]
9. Assessment of epigenetic alterations in early colorectal lesions containing BRAF mutations. Sawada T, Yamamoto E, Yamano HO, Nojima M, Harada T, Maruyama R, Ashida M, Aoki H, Matsushita HO, Yoshikawa K, Harada E, Tanaka Y, Wakita S, Niinuma T, Kai M, Eizuka M, Sugai T, Suzuki H. Oncotarget; 2016 Jun 07; 7(23):35106-18. PubMed ID: 27145369 [Abstract] [Full Text] [Related]
10. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Kim YH, Kakar S, Cun L, Deng G, Kim YS. Int J Cancer; 2008 Dec 01; 123(11):2587-93. PubMed ID: 18798261 [Abstract] [Full Text] [Related]
11. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ. Am J Surg Pathol; 2004 Nov 01; 28(11):1452-9. PubMed ID: 15489648 [Abstract] [Full Text] [Related]
12. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia. Tanaka Y, Yamano HO, Yamamoto E, Matushita HO, Aoki H, Yoshikawa K, Takagi R, Harada E, Nakaoka M, Yoshida Y, Eizuka M, Sugai T, Suzuki H, Nakase H. Gastrointest Endosc; 2017 Dec 01; 86(6):1131-1138.e4. PubMed ID: 28501592 [Abstract] [Full Text] [Related]
13. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Kimura T, Yamamoto E, Yamano HO, Suzuki H, Kamimae S, Nojima M, Sawada T, Ashida M, Yoshikawa K, Takagi R, Kato R, Harada T, Suzuki R, Maruyama R, Kai M, Imai K, Shinomura Y, Sugai T, Toyota M. Am J Gastroenterol; 2012 Mar 01; 107(3):460-9. PubMed ID: 22233696 [Abstract] [Full Text] [Related]
14. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. Naito T, Nosho K, Ito M, Igarashi H, Mitsuhashi K, Yoshii S, Aoki H, Nomura M, Sukawa Y, Yamamoto E, Adachi Y, Takahashi H, Hosokawa M, Fujita M, Takenouchi T, Maruyama R, Suzuki H, Baba Y, Imai K, Yamamoto H, Ogino S, Shinomura Y. World J Gastroenterol; 2014 Aug 07; 20(29):10050-61. PubMed ID: 25110432 [Abstract] [Full Text] [Related]
15. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H, Galván JA, Helbling M, Muller DE, Karamitopoulou E, Koelzer VH, Economou M, Hammer C, Lugli A, Zlobec I. Int J Cancer; 2014 May 15; 134(10):2342-51. PubMed ID: 24166180 [Abstract] [Full Text] [Related]
16. Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions. Tsai JH, Cheng CH, Chen CC, Lin YL, Lin LI, Chen ML, Liau JY. Histopathology; 2016 May 15; 68(6):810-8. PubMed ID: 26496853 [Abstract] [Full Text] [Related]
17. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum. Wiland HO, Shadrach B, Allende D, Carver P, Goldblum JR, Liu X, Patil DT, Rybicki LA, Pai RK. Am J Surg Pathol; 2014 Sep 15; 38(9):1290-7. PubMed ID: 25127095 [Abstract] [Full Text] [Related]
18. Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway. Nosho K, Igarashi H, Nojima M, Ito M, Maruyama R, Yoshii S, Naito T, Sukawa Y, Mikami M, Sumioka W, Yamamoto E, Kurokawa S, Adachi Y, Takahashi H, Okuda H, Kusumi T, Hosokawa M, Fujita M, Hasegawa T, Okita K, Hirata K, Suzuki H, Yamamoto H, Shinomura Y. Carcinogenesis; 2014 Apr 15; 35(4):776-83. PubMed ID: 24242331 [Abstract] [Full Text] [Related]
19. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway. Aoki H, Yamamoto E, Yamano HO, Sugai T, Kimura T, Tanaka Y, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Nakaoka M, Yoshida Y, Harada T, Sudo G, Eizuka M, Yorozu A, Kitajima H, Niinuma T, Kai M, Nojima M, Suzuki H, Nakase H. Dig Dis Sci; 2018 Jul 15; 63(7):1920-1928. PubMed ID: 29546645 [Abstract] [Full Text] [Related]
20. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Leggett B, Whitehall V. Gut; 2017 Jan 15; 66(1):97-106. PubMed ID: 26475632 [Abstract] [Full Text] [Related] Page: [Next] [New Search]